Skip to main content
Signal8

Medpace Holdings, Inc. (MEDP)

Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.

Sector: Services-Commercial Physical & Biological Research

Industry: Medical - Diagnostics & Research

Medpace Holdings, Inc. logo

Medpace Holdings, Inc.

NASDAQ:MEDPHealthcare
+2.33%$669.20
AH Close$669.20+0.00%vs close
Mkt Cap$18.72B
Float22.5M
O/S27.97M
Inst Own87.8%
SI7.1%
Dilution
Medpace Holdings, Inc. logoNASDAQ:MEDP$669.20+2.33%
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$18.72B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership87.76%

based on 27.97M shares outstanding

SectorHealthcare
IndustryMedical - Diagnostics & Research
ExchangeNASDAQ
CountryUSUS
IPO DateAug 11, 2016
Shares Outstanding27.97M
Float22.50M
Company Overview

Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services.

The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia.

Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.

Leadership

August J. Troendle

Chief Executive Officer and Chairman of the Board

Brian T. Carley

Director

Cornelius P. McCarthy III

Director

Dani S. Zander

Director

Employees

7K+

Country

US

Sector

Healthcare

Website

medpace.com

Analyst Coverage
Analyst Coverage
ConsensusHold
Price Target
No price targets available
Ratings Distribution
BUY
4
HOLD
14
SELL
1
TOTAL19
Insider Trading
InsiderTypeShares
BURWIG SUSAN E profile photoBURWIG SUSAN EOption Exercise2.7K
BURWIG SUSAN E profile photoBURWIG SUSAN EOption Exercise2.7K
BURWIG SUSAN E profile photoBURWIG SUSAN EOption Exercise3.0K
BURWIG SUSAN E profile photoBURWIG SUSAN EOption Exercise3.0K
BURWIG SUSAN E profile photoBURWIG SUSAN EOption Exercise2.0K
BURWIG SUSAN E profile photoBURWIG SUSAN EOption Exercise2.0K
Shareholders
87.8%
Institutional
(714)
0.6%
Insiderⓘ
(9)
19.3%
5%+ Owners
(1)
-
Unattributed (incl. retail)ⓘ
Institutional87.8%
Insider0.6%
5%+ Beneficial19.3%
Sources: 13F, Form 4, 13D/13GO/S: 28.0M · as of 16 Oct 2026 · SEC cover page
Insiders & Institutional Holders
52-Week Range
$373.00$684.52
$669.20(95th percentile)
Volume
Average Daily Volume336.42K
309.31K today vs 336.42K avg(-8%)

30d Avg

336.42K

60d Avg

284.18K

90d Avg

272.51K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...